Histotype-specific copy-number alterations in ovarian cancer.
about
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapyPotential targets for ovarian clear cell carcinoma: a review of updates and future perspectivesAberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancerAn integrative approach identified genes associated with drug response in gastric cancer.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer.Optimizing Ventana chromogenic dual in-situ hybridization for mucinous epithelial ovarian cancer.Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.In vivo tumor growth of high-grade serous ovarian cancer cell linesGRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use.Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancerGenome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer.CAISMOV24, a new human low-grade serous ovarian carcinoma cell line.
P2860
Q26769604-6FD85002-36C9-4285-8D6C-3EC82B484907Q26775315-CDBA94B1-B6F7-4BF1-8D2B-85D112D6DF28Q28543351-5FD826B7-1EF3-4210-A0CC-CD9891B75EE5Q34465851-C34B0AB8-FA8D-42DA-BAFE-E561737B1FA8Q34528553-F6A2AFF9-A0BA-4C9E-AE7E-5B1B41476AE2Q34688984-80485138-5B53-4F55-AA63-E7B88CD6232CQ35076986-F3334757-9ABD-44F2-9F9E-7F5EC878BC96Q35652910-67CA9CFD-1FFC-4A9B-AEB6-223517D22684Q35927115-702DDF78-C505-43C8-AB99-B4BC442D373EQ36591554-2042C4E7-E43C-4060-BB50-2E0B36C1951FQ36829194-FB66D91E-CC39-49EA-81F2-6F84CB58FE61Q37174032-D4556E07-EE0D-4FD7-8A11-1F2613349F1DQ37716509-926AE38C-4F80-4016-BB3D-7EBA130B82E7Q38256465-5C4F4043-ED8F-4579-8001-B0D622207E1CQ46357857-8BFB7393-D101-484E-9188-1E186791379BQ47581360-97D337E3-D366-40B6-AE49-843D830522EE
P2860
Histotype-specific copy-number alterations in ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Histotype-specific copy-number alterations in ovarian cancer.
@ast
Histotype-specific copy-number alterations in ovarian cancer.
@en
Histotype-specific copy-number alterations in ovarian cancer.
@nl
type
label
Histotype-specific copy-number alterations in ovarian cancer.
@ast
Histotype-specific copy-number alterations in ovarian cancer.
@en
Histotype-specific copy-number alterations in ovarian cancer.
@nl
prefLabel
Histotype-specific copy-number alterations in ovarian cancer.
@ast
Histotype-specific copy-number alterations in ovarian cancer.
@en
Histotype-specific copy-number alterations in ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Histotype-specific copy-number alterations in ovarian cancer.
@en
P2093
Geng Bo Chen
Hung-Cheng Lai
Ikuo Konishi
Jean-Paul Thiery
Jingjing Li
Meng Kang Wong
Noriomi Matsumura
Ruby Yunju Huang
Seiichi Mori
P2860
P2888
P356
10.1186/1755-8794-5-47
P577
2012-10-18T00:00:00Z
P5875
P6179
1014129131